背景:激励肺活量测定(IS)作为围手术期的常规呼吸治疗已在临床实践中广泛使用。然而,IS对围手术期肺癌患者的影响仍存在争议.本文旨在评价IS在肺癌患者围手术期肺康复中的应用效果。
方法:Cochrane图书馆,PubMed,WebofScience,奥维德,CINAHL,中国国家知识基础设施,维普,和万方数据库从开始到2023年11月30日进行了搜索。本系统评价仅包括随机对照试验。PRISMA检查表作为进行本次审查的指导。纳入研究的质量评估通过Cochrane偏倚风险工具进行评估。使用ReviewManager5.4进行荟萃分析。此外,还进行了敏感性分析和亚组分析.
结果:9项研究招募了1209名符合我们纳入标准的患者。观察到IS联合其他呼吸治疗技术可降低术后肺部并发症的发生率,增强肺功能,缩短住院时间,降低博格的得分.然而,6分钟步行距离或生活质量评分均无改善.
结论:尽管IS作为肺癌患者围手术期综合干预措施的组成部分显示出益处,事实证明,确定IS作为综合干预措施中的独立组成部分的确切影响具有挑战性。因此,需要进一步的研究,以更好地了解IS隔离的有效性及其与这些患者的额外呼吸治疗的相互作用.
背景:PROSPERO,https://www.crd.约克。AC.英国/普华永道/,注册表号:CRD42022321044。
BACKGROUND: Incentive spirometry (IS) as a routine respiratory therapy during the perioperative period has been widely used in clinical practice. However, the impact of IS on patients with perioperative lung cancer remains controversial. This review aimed to evaluate the efficacy of IS in perioperative pulmonary rehabilitation for patients with lung cancer.
METHODS: Cochrane Library, PubMed, Web of Science, Ovid, CINAHL, Chinese National Knowledge Infrastructure, Weipu, and Wanfang Databases were searched from inception to 30 November 2023. Only randomized controlled trials were included in this systematic review. The PRISMA checklist served as the guidance for conducting this review. The quality assessment of the included studies was assessed by the Cochrane risk-of-bias tool. The meta-analysis was carried out utilizing Review Manager 5.4. Furthermore, sensitivity analysis and subgroup analysis were also performed.
RESULTS: Nine studies recruited 1209 patients met our inclusion criteria. IS combined with other respiratory therapy techniques was observed to reduce the incidence of postoperative pulmonary complications, enhance pulmonary function, curtail the length of hospital stay, and lower the Borg score. Nevertheless, no improvements were found in the six-minute walk distance or quality of life score.
CONCLUSIONS: Although IS demonstrates benefits as a component of comprehensive intervention measures for perioperative patients with lung cancer, it proves challenging to determine the precise impact of IS as a standalone component within the comprehensive intervention measures. Therefore, further researches are required to better understand the effectiveness of IS isolation and its interactions when integrated with additional respiratory therapies for these patients.
BACKGROUND: PROSPERO, https://www.crd.york.ac.uk/prospero/ , registry number: CRD42022321044.